Tag: Sarah Stoiber
Three firms act on BioNTech’s USD950m China partner buyout
A&O Shearman, Goodwin, and Conyers are advising BioNTech on its $950M buyout of a Chinese cancer drug partner to rival Merck
A&O Shearman, Goodwin, and Conyers are advising BioNTech on its $950M buyout of a Chinese cancer drug partner to rival Merck
More than 70 legal experts and industry leaders shared insights at our Beijing forum, exploring solutions to businesses’ key legal challenges